HOME Top Market Reports European Injectable Drug Delivery Market By Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Forecasts to 2017

European Injectable Drug Delivery Market By Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Forecasts to 2017

By: marketsandmarkets.com
Publishing Date: July 2013
Report Code: BT 2073

Discount on Reports  

  Speak to Analyst Enquiry Before Buying
 
purchase report
download pdf  request for customisation


The European injectable drug delivery market was valued at $6.8 billion in 2012, and is expected to reach $12.4 billion by 2017 at a CAGR of 12.7% from 2012 to 2017. Injectable drug delivery technologies are a combination of two major segments - devices and formulations. The European injectable drug delivery formulations technologies market is the largest segment in the market. This is due to a surge of biologics and development of nanotechnologies. In addition, the market is segmented on the basis of its therapeutic applications. In the therapeutic field, hormonal disorders command the major segment due to the high demand of injectable in the treatment of diabetes.

The growth of the injectable drug delivery technologies market is primarily triggered by favorable reimbursement policies on injectable drugs and devices, technological advancements, surge of biologics in pharmaceutical markets, rising incidences of cancer and diabetes in Europe, and improving patient compliance. The evolving opportunities in this market for manufacturers include development of biosimilars in pharmaceutical markets and focus of pharmaceutical manufacturers towards emerging markets such as Spain, Russia, Denmark, Ireland and others. However, factors such as needle-stick injuries and infections and development of alternate delivery methods are restraining the growth of the market.

Germany accounted for the largest market share of the European injectable drug delivery market in 2012, followed by France. While Germany is a mature market experiencing a surge in biologics and high incidence of chronic diseases, France is the fastest-growing region. This is due to high insurance coverage for injectable devices and formulations, affordability for healthcare expenses, and activities such as exhibitions and conferences hosted by France that address injectable drug delivery technologies. The other European regions of Spain, Italy and Russia show high export potential for plastic syringes and needle, rising support for generics market, and increasing expenditure in the healthcare sector. The regions of Switzerland, Denmark, Ireland, Greece, Hungary, the Netherlands, Poland, Portugal, Romania, and Ukraine provide benefits such as favorable environment for research and development, growth in diabetic expenditures, and favorable reimbursement policies for injectable devices.

The key players in this market are Becton Dickinson & Co. (U.S.), Baxter International, Inc. (U.S.), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), Eli Lily & Co. (U.S.), Gerresheimer AG (Germany), Sanofi (France), West Pharmaceutical Services, Inc. (U.S.), Haselmeier GmbH (Germany), and Owen Mumford, Ltd. (U.K.).

Scope of the Report

This research report categorizes the European injectable drug delivery technologies market into two segments, namely, Europe injectable drug delivery devices technologies and European injectable drug delivery formulations technologies. These markets are broken down into segments and sub-segments, providing value analysis for 2010, 2011, and 2012, as well as forecast up to 2017. Each market is comprehensively analyzed by geography (Germany, France, U.K., Spain, Italy, Russia and Rest of Europe (RoE)) to provide in-depth information on the European scenario.

Europe Injectable Drug Delivery Technologies Market, By Segment

  • Injectable Drug Delivery Devices Technologies
  • Injectable Drug Delivery Formulations Technologies

Europe Injectable Drug Delivery Devices Technologies Market, By Product

  • Conventional Injection Devices
  • By Materials
    • Glass
    • Plastics
  • By Products
    • Fillable Syringes
    • Prefilled Syringes
  • By Usability
    • Reusable
    • Disposable
  • Self-Injection Devices
  • Needle Free Injectors
    • By Product
      • Fillable Syringes
      • Prefilled Syringes
    • By Technology
      • Jet-based Needle Free Injectors
      • Spring-based Needle Free Injectors
      • Laser Powered Needle Free Injectors
      • Others
    • By Usability
      • Reusable
      • Disposable
  • Auto Injectors
    • By Products
      • Fillable Syringes
      • Prefilled Syringes
    • By Technology
      • Manual Injection Auto Injectors
      • Automated Injection Auto Injectors
    • By Design
      • Standardized Auto Injectors
      • Customized Auto Injectors
    • By Usability
      • Reusable
      • Disposable
  • Pen Injectors
    • By Products
      • Single Chambered Pen Injectors
      • Dual Chambered Pen Injectors
    • By design
      • Standardized pen injectors
      • Customized pen injectors
    • By usability
      • Reusable
      • Disposable
  • Others (blunt-needle, micro needle, and nano needle injections)

    Europe Injectable Drug Delivery Formulations Technologies, By Product

    • Conventional Drug Delivery Formulations
      • Solution
      • Reconstituted / Lyophilized Formulations
    • Novel Drug Delivery Formulations
      • Liposomal Systems
      • Microspheres
      • Nanoparticles
      • Polymeric Micelles
      • Others (dendrimers, nanosponge, and nanoemulsions)

    Europe Injectable Drug Delivery Technologies Market, By Therapeutic Applications

    • Auto-immune Diseases
      • Multiple Sclerosis
      • Rheumatoid Arthritis
      • Crohn's Diseases
      • Psoriasis
      • Others
    • Hormonal Disorders
      • Diabetes
      • Antithrombotic/Thrombolytic Therapy
      • Reproductive Health Diseases
      • Anemia
      • Osteoporosis
      • Others
    • Orphan Diseases
    • Oncology
    • Others
      • Pain Management
      • Allergies
      • Hepatitis C
      • Aesthetic Treatment

    Europe Injectable Drug Delivery Technologies Market, By Geography

    • Germany
    • France
    • U.K.
    • Spain
    • Italy
    • Russia
    • Rest of Europe

      Customer Interested in this report also can view

      • North America Injectable Drug Delivery Market by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] Forecasts to 2017

      • Injectable Drug Delivery Market by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Global Forecasts to 2017

    • Table Of Contents 
       
      1 Introduction (Page No. - 26)
        1.1 Key Take-Aways
        1.2 Report Description
        1.3 Markets Covered
        1.4 Stakeholders
        1.5 Research Methodology
            1.5.1 Market Size
            1.5.2 Market Share
            1.5.3 Key Data Points From Secondary Sources
            1.5.4 Key Data Points From Primary Sources
            1.5.5 Assumptions

      2 Executive Summary (Page No. - 34)

      3 Market Overview (Page No. - 39)
        3.1 Introduction
        3.2 Market Segmentation
        3.3 Market Dynamics
            3.3.1 Drivers
                  3.3.1.1 Technological Advancements
                  3.3.1.2 Favorable Reimbursement Environment To Bolster The Demand Of Self Injection Devices
                  3.3.1.3 Surge Of Biologics In European Pharmaceutical Market
                  3.3.1.4 Rising Incidences Of Cancer And Diabetes
                  3.3.1.5 Improving Patient Compliance
            3.3.2 Restraints
                  3.3.2.1 Needle-Stick Injuries And Infections
                  3.3.2.2 Threat From Alternate Drug Delivery Methods
                  3.3.2.3 Slow Approval Process Of Drugs And Medical Devices In Europe
            3.3.3 Opportunities
                  3.3.3.1 Development Of Biosimilars In The European Pharmaceutical Market
                  3.3.3.2 Need For Better Healthcare For The Increasing Geriatric Population Of Europe
            3.3.4 Challenges
                  3.3.4.1 Sustainability Of Players In Highly Competitive Market
        3.4 Market Share Analysis, By Major Players
            3.4.1 Conventional Injectable Drug Delivery Devices
            3.4.2 Self-Injection Devices-Pen Injectors

      4 European Injectable Drug Delivery Devices Technologies Market (Page No. - 65)
        4.1 Introduction
        4.2 Market Segmentation
        4.3 Manufacturers Criteria For Selection Of An Injectable Device
        4.4 Conventional Injectable Drug Delvery Devices
            4.4.1 By Usability
                  4.4.1.1 Disposable
                  4.4.1.2 Reusable
            4.4.2 By Material
                  4.4.2.1 Glass
                  4.4.2.2 Plastic
            4.4.3 By Product
                  4.4.3.1 Fillable
                  4.4.3.2 Prefilled
        4.5 Self-Injection Devices
            4.5.1 Market Segmentation
            4.5.2 Selection Criteria For Self-Injection Device
            4.5.3 Pen Injectors
                  4.5.3.1 By Product
                          4.5.3.1.1 Single Chamber Pen Injectors
                          4.5.3.1.2 Dual Chamber Pen Injectors
                  4.5.3.2 By Usability
                          4.5.3.2.1 Disposable Pen Injectors
                          4.5.3.2.2 Reusable Pen Injectors
                  4.5.3.3 By Design
                          4.5.3.3.1 Standard Pen Injectors
                          4.5.3.3.2 Customized Pen Injectors
            4.5.4 Needle-Free Injectors
                  4.5.4.1 By Product
                          4.5.4.1.1 Prefilled Needle Free Injectors
                          4.5.4.1.2 Fillable Needle Free Injectors
                  4.5.4.2 By Technology
                          4.5.4.2.1 Jet-Based Needle-Free Injectors
                          4.5.4.2.2 Spring-Based Needle-Free Injectors
                          4.5.4.2.3 Laser-Based Needle Free Injectors
                          4.5.4.2.4 Vibration-Based Needle Free Injectors
                  4.5.4.3 By Usability
                          4.5.4.3.1 Disposable
                          4.5.4.3.2 Reusable
            4.5.5 Auto Injectors
                  4.5.5.1 By Product
                          4.5.5.1.1 Prefilled Auto Injectors
                          4.5.5.1.2 Fillable Auto Injectors
                  4.5.5.2 By Technology
                          4.5.5.2.1 Automated Auto Injectors
                          4.5.5.2.2 Manual Auto Injectors
                  4.5.5.3 By Design
                          4.5.5.3.1 Standardized Auto Injectors
                          4.5.5.3.2 Customized Auto Injectors
                  4.5.5.4 By Usability
                          4.5.5.4.1 Disposable Auto Injectors
                          4.5.5.4.2 Reusable Auto Injectors
        4.6 Others

      5 European Injectable Drug Delivery Formulation Technologies Market (Page No. - 141)
        5.1 Introduction
        5.2 Conventional Drug Delivery
            5.2.1 Injectable Solutions
            5.2.2 Reconstituted/Lyophilized Formulations
        5.3 Novel Drug Delivery Formulation Technologies
            5.3.1 Market Segmentation
            5.3.2 Liposomal Systems
            5.3.3 Microspheres
            5.3.4 Nanoparticles
            5.3.5 Polymeric Micelles
            5.3.6 Others

      6 European Injectable Drug Delivery Technologies Market, By Therapeutic Applications (Page No. - 168)
        6.1 Introduction
        6.2 Auto-Immune Diseases
            6.2.1 Multiple Sclerosis
            6.2.2 Rheumatoid Arthritis
            6.2.3 Crohn's Diseases
            6.2.4 Psoriasis
            6.2.5 Others
        6.3 Hormonal Disorders
            6.3.1 Diabetes
            6.3.2 Anemia
            6.3.3 Reproductive Health Diseases
            6.3.4 Antithrombotic/Thrombolytic Therapy
            6.3.5 Osteoporosis
            6.3.6 Growth Hormone Deficiency
        6.4 Orphan/Rare Diseases
        6.5 Oncology
        6.6 Others
            6.6.1 Pain Management
            6.6.2 Hepatitis C
            6.6.3 Allergies
            6.6.4 Aesthetic Treatment

      7 Geographic Analysis (Page No. - 215)
        7.1 Introduction
        7.2 Germany
            7.2.1 More Than 25 New Medicines Are Due For Marketing License In Germany For The Year 2013 
        7.3 France
            7.3.1 Higher Insurance Coverage, Increase In Aging Population And Affordability Drives The Market In France
        7.4 U.K.
            7.4.1 Highest Turnover Of Antibiotics And Small Molecules Due To Oncology And Infections
            7.4.2 Bioscience & Health Technology Database Provide Better Industry Data On Injectable Technologies
        7.5 Spain
            7.5.1 Spain Is Amongst The Top 10 Countries With Highest Expenditure On Diabetes
        7.6 Italy
            7.6.1 Removal Of Linkages Between Patent And Generic Medicines Causes Rapid Access To Generics In Italy
        7.7 Russia
            7.7.1 Russian Government Aimed To Foster The Development Of Healthcare System
        7.8 Rest Of Europe
            7.8.1 Switzerland Has The Most Competitive Economy And Has Leading Position In Global Pharmaceuticals And Biotech Industries
            7.8.2 Denmark Provides For Concentrated Patient Pool Especially For Diabetes Due To Centralization Of Healthcare System
            7.8.3 High Acceptability For New Technologies And Lowest Corporate Tax Rate Drives The Ireland Market
            7.8.4 Favorable Growth In Regions Of Portugal, Poland, And Romania Due To Increasing Diabetes Incidence And Related Reimbursement Policies

      8 Competitive Landscape (Page No. - 251)
        8.1 Introduction
        8.2 Expansion
        8.3 Agreements, Partnerships, Collaborations & Joint Ventures 
        8.4 New Product Launch
        8.5 Mergers & Acquisitions
        8.6 Other Developments

      9 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)*  (Page No. - 277)
        9.1 Alkermes, Inc.
        9.2 Bespak Europe, Ltd. (Subsidiary Of Consort Medical, Plc) 
        9.3 Crossject
        9.4 Gerresheimer AG
        9.5 Haselmeier Gmbh
        9.6 Injex Pharma Gmbh (Subsidiary Of Hns International, Inc.) 
        9.7 Novo Nordisk A/S
        9.8 Owen Mumford, Ltd.
        9.9 Sanofi
        9.10 Schott AG
        9.11 Vetter Pharma-Fertigung Gmbh & Co. KG
        9.12 Ypsomed Holding AG
        *Details On Financials, Product & Services, Strategy, & Developments Might Not Be Captured In Case Of Unlisted Companies. 
       
       
      List Of Tables  (143 Tables)
       
      Table 1 Europe Injectable Drug Delivery Technologies Market, By Segment, 2010 2017 ($Million) 
      Table 2 Europe Injectable Drug Delivery Technologies Market, By Segment, 2010 2017 ($Million) 
      Table 3 Injection Drug Delivery Technologies Market, By Geography, 2010 2017 ($Million)
      Table 4 Europe Injectable Drug Delivery Devices Technologies Market, By Product, 2010 2017 ($Million)
      Table 5 Injection Drug Delivery Devices Technologies Market, By Geography, 2010 2017 ($Million) 
      Table 6 Conventional Injection Devices Market, By Geography, 2010 2017 ($Million) 
      Table 7 European Conventional Injection Devices Market, By Usability, 2010 2017 ($Million) 
      Table 8 Disposable Conventional Devices Market, By Geography, 2010 2017 ($Million) 
      Table 9 Reusable Conventional Devices Market, By Geography, 2010 2017 ($Million) 
      Table 10 European Conventional Injection Devices Market, By Material, 2010 2017 ($Million) 
      Table 11 Conventional Injection Devices (Glass) Market, By Geography, 2010 2017 ($Million) 
      Table 12 Conventional Injection Devices (Plastic) Market, By Geography, 2010 2017 ($Million) 
      Table 13 European Conventional Injection Devices Market, By Product, 2010 2017 ($Million) 
      Table 14 Fillable Conventional Injection Devices Market, By Geography, 2010 2017 ($Million) 
      Table 15 Prefilled Conventional Injection Devices Market, By Geography, 2010 2017 ($Million) 
      Table 16 Major Therapeutic Areas For Self-Injection Devices
      Table 17 Europe Self-Injection Devices Market, By Product, 2010 2017 ($Million) 
      Table 18 Self-Injection Devices Market, By Geography, 2010 2017 ($Million) 
      Table 19 Pen Injector Market, By Geography, 2010 2017 ($Million)
      Table 20 European Pen Injectors Market, By Product, 2010 2017 ($Million) 
      Table 21 Single Chamber Pen Injector Market, By Geography, 2010 2017 ($Million) 
      Table 22 Dual Chamber Pen Injector Market, By Geography, 2010 2017 ($Million) 
      Table 23 European Pen Injectors Market, By Usability, 2010 2017 ($Million) 
      Table 24 Disposable Pen Injectors Market, By Geography, 2010 2017 ($Million) 
      Table 25 Reusable Pen Injectors Market, By Geography, 2010 2017 ($Million) 
      Table 26 European Pen Injectors Market, By Design, 2010 2017 ($Million) 
      Table 27 Standard Pen Injectors Market, By Geography, 2010 2017 ($Million) 
      Table 28 Customized Pen Injectors Market, By Geography, 2010 2017 ($Million) 
      Table 29 Needle Free Injectors Market, By Geography, 2010 2017 ($Million) 
      Table 30 European Needle Free Injectors Market, By Product, 2010 2017 ($Million) 
      Table 31 Prefilled Needle Free Injectors Market, By Geography, 2010 2017 ($Million) 
      Table 32 Fillable Needle Free Injectors Market, By Geography, 2010 2017 ($Million) 
      Table 33 European Needle Free Injectors Market, By Technology, 2010 2017 ($Million) 
      Table 34 Jet-Based Needle Free Injector Market, By Geography, 2010 2017 ($Million) 
      Table 35 Spring-Based Needle Free Injector Market, By Geography, 2010 2017 ($Million)
      Table 36 Laser-Powered Needle Free Injector Market, By Geography, 2010 2017 ($Million)
      Table 37 Vibration-Based Needle Free Injector Market, By Geography, 2010 2017 ($Million)
      Table 38 Europe Needle Free Injectors Market, By Usability, 2010 2017 ($Million) 
      Table 39 Disposable Needle Free Injectors Market, By Geography, 2010 2017 ($Million) 
      Table 40 Reusable Needle Free Injectors Market, By Geography, 2010 2017 ($Million) 
      Table 41 Auto Injectors Products Market, By Geography, 2010 2017 ($Million) 
      Table 42 Europe Auto Injectors Market, By Product, 2010 2017 ($Million) 
      Table 43 Prefilled Auto Injectors Market, By Geography, 2010 2017 ($Million) 
      Table 44 Fillable Auto Injectors Market, By Geography, 2010 2017 ($Million) 
      Table 45 Europe Auto Injectors Market, By Technology, 2010 2017 ($Million) 
      Table 46 Automated Auto Injectors Market, By Geography, 2010 2017 ($Million) 
      Table 47 Manual Auto Injectors Market, By Geography, 2010 2017 ($Million) 
      Table 48 Europe Auto Injectors Market, By Design, 2010 2017 ($Million) 
      Table 49 Standardized Auto Injectors Market, By Geography,2010 2017 ($Million) 
      Table 50 Customized Auto Injectors Auto Injectors Market, By Geography, 2010 2017 ($Million) 
      Table 51 Europe Auto Injectors Market, By Usability, 2010 2017 ($Million) 
      Table 52 Disposable Auto Injectors Market, By Geography, 2010 2017 ($Million) 
      Table 53 Reusable Auto Injectors Market, By Geography, 2010 2017 ($Million) 
      Table 54 Others Injectors Market, By Geography, 2010 2017 ($Million) 
      Table 55 Europe Injectable Drug Delivery Formulation Technologies Market, By Segment, 2010 2017 ($Million)
      Table 56 Injectable Drug Delivery Formulation Technologies Market, By Geography, 2010 2017 ($Million)
      Table 57 Europe Conventional Drug Delivery Formulation Technologies Market, 2010 2017 ($Million)
      Table 58 Conventional Drug Delivery Formulation Technologies Market, By Geography, 2010 2017 ($Million)
      Table 59 Injectable Solutions Conventional Drug Delivery Formulation Market, By Geography, 2010 2017 ($Million)
      Table 60 Reconstituted/Lyophilized Conventional Drug Delivery Formulation Market, By Geography, 2010 2017 ($Million)
      Table 61 Novel Drug Delivery Formulation Technologies Market, 2010 2017 ($Million) 
      Table 62 Novel Drug Delivery Formulation Technologies Market, By Geography, 2010 2017 ($Million) 
      Table 63 Liposome Drug Delivery Formulation Market, By Geography, 2010 2017 ($Million)
      Table 64 Microspheres Drug Delivey Formulation Market, By Geography, 2010 2017 ($Million) 
      Table 65 Nanoparticles Drug Delivey Formulation Market, By Geography, 2010 2017 ($Million) 
      Table 66 Polymeric Micelles Drug Delivey Formulation Market, By Geography, 2010 2017 ($Million) 
      Table 67 Other Novel Drug Delivey Formulation Market, By Geography, 2010 2017 ($Million)
      Table 68 Europe Injectable Drug Delivery Technologies Market, By Therapeutic Application, 2010 2017 ($Million) 
      Table 69 Europeauto-Immune Therapeutic Market, By Indication, 2010 2017 ($Million) 
      Table 70 Auto-Immune Therapeutic Market,By Geography, 2010 2017 ($Million) 
      Table 71 Multiple Sclerosis Market, By Geography, 2010 2017 ($Million) 
      Table 72 Rheumatoid Arthritis Market, By Geography, 2010 2017 ($Million) 
      Table 73 Crohn's Diseases Market, By Geography, 2010 2017 ($Million) 
      Table 74 Psoriasis Market, By Geography, 2010 2017 ($Million)
      Table 75 Other Auto-Immune Diseases Market, By Geography, 2010 2017 ($Million) 
      Table 76 Europe Hormonal Disorders, By Indication, 2010 2017 ($Million) 
      Table 77 Hormonal Disorders Market, By Geography, 2010 2017($Million) 
      Table 78 Diabetes Market, By Geography, 2010 2017 ($Million)
      Table 79 Anemia Market, By Geography, 2010 2017 ($Million)
      Table 80 Reproductive Health Diseases Market, By Geography,2010 2017($Million) 
      Table 81 Antithrombotic Therapy Market, By Geography, 2010 2017 ($Million) 
      Table 82 Osteoporosis Market, By Geography, 2010 2017 ($Million)
      Table 83 Growth Hormone Deficiency Market, By Geography, 2010 2017 ($Million) 
      Table 84 Orphan/Rare Diseases Therapeutic Market, By Geography, 2010 2017 ($Million)
      Table 85 Oncology Therapeutic Market, By Geography, 2010 2017 ($Million) 
      Table 86 European Other Therapeutic Market, 2010 2017 ($Million)
      Table 87 Other Therapeutic Market, By Geography, 2010 2017 ($Million) 
      Table 88 Pain Management Market, By Geography, 2010 2017 ($Million)
      Table 89 Hepatitis C Market, By Geography, 2010 2017 ($Million)
      Table 90 Allergies/Anaphylytic Shock Market, By Geography, 2010 2017 ($Million) 
      Table 91 Aesthetic Treatment Market, By Geography, 2010 2017 ($Million) 
      Table 92 Germany: Injectable Drug Delivery Technologies Market, 2010 2017 ($Million)
      Table 93 Germany: Injectable Drug Delivery Devices Technologies Market, By Segment, 2010 2017 ($Million)
      Table 94 Germany: Injectable Drug Delivery Formulation Technologies Market, 2010 2017 ($Million)
      Table 95 Germany: Injectable Drug Delivery Technologies Market, By Therapeutic Application, 2010 2017 ($Million) 
      Table 96 France: Injectable Drug Delivery Technologies Market, 2010 2017 ($Million) 
      Table 97 France: Injectable Drug Delivery Devices Technologies Market, By Segment, 2010 2017 ($Million)
      Table 98 France: Injectable Drug Delivery Formulation Technologies Market, 2010 2017 ($Million)
      Table 99 France: Injectable Drug Delivery Technologies Market, By Therapeutic Application 2010 2017 ($Million) 
      Table 100 U.K.: Injectable Drug Delivery Technologies Market, 2010 2017 ($Million) 
      Table 101 U.K.: Injectable Drug Delivery Devices Technologies Market, By Segment, 2010 2017 ($Million)
      Table 102 U.K.: Injectable Drug Delivery Formulation Technologies Market, 2010 2017 ($Million)
      Table 103 U.K.: Injectable Drug Delivery Technologies Market, By Therapeutic Application 2010 2017 ($Million) 
      Table 104 Spain: Injectable Drug Delivery Technologies Market, 2010 2017 ($Million) 
      Table 105 Spain: Injectable Drug Delivery Devices Technologies Market, By Segment, 2010 2017 ($Million)
      Table 106 Spain: Injectable Drug Delivery Formulation Technologies Market, 2010 2017 ($Million)
      Table 107 Spain: Injectable Drug Delivery Technologies Market, By Therapeutic Application 2010 2017 ($Million) 
      Table 108 Italy: Injectable Drug Delivery Technologies Market, 2010 2017 ($Million) 
      Table 109 Italy: Injectable Drug Delivery Devices Technologies Market, By Segment, 2010 2017 ($Million)
      Table 110 Italy: Injectable Drug Delivery Formulation Technologies Market, 2010 2017 ($Million)
      Table 111 Italy: Injectable Drug Delivery Technologies Market, By Therapeutic Application 2010 2017 ($Million) 
      Table 112 Russia: Injectable Drug Delivery Technologies Market, 2010 2017 ($Million) 
      Table 113 Russia: Injectable Drug Delivery Devices Technologies Market, By Segment, 2010 2017 ($Million)
      Table 114 Russia: Injectable Drug Delivery Formulation Technologies Market, 2010 2017 ($Million)
      Table 115 Russia: Injectable Drug Delivery Technologies Market, By Therapeutic Application 2010 2017 ($Million) 
      Table 116 ROE: Injectable Drug Delivery Technologies Market, 2010 2017 ($Million) 
      Table 117 ROE: Injectable Drug Delivery Devices Technologies Market, By Segment, 2010 2017 ($Million)
      Table 118 ROE: Injectable Drug Delivery Formulation Technologies Market, 2010 2017 ($Million)
      Table 119 ROE: Injectable Drug Delivery Technologies Market, By Therapeutic Application 2010 2017 ($Million) 
      Table 120 Expansion, 2010 2013
      Table 121 Agreements, Partnerships, Collaborations & Joint Ventures, 2010 2013
      Table 122 New Product Launch, 2010 2013
      Table 123 Mergers & Acquisitions, 2010 2013
      Table 124 Other Developments, 2010 2013
      Table 125 Alkermes: Total Revenue And R&D Expenses, 2009 2011 ($Million) 
      Table 126 Alkermes: Total Revenue, By Geography, 2009 2011 ($Million)
      Table 127 Consort Medical: Total Revenue And R&D Expense, 2009 2011 ($Million) 
      Table 128 Consort Medical: Total Revenue, By Geography, 2009 2011 ($Million) 
      Table 129 Gerresheimer Ag: Total Revenue And R&D Expenses, 2010 2012 ($Million) 
      Table 130 Gerresheimer Ag: Total Revenue, By Segment, 2010 2012 ($Million) 
      Table 131 Gerresheimer Ag: Total Revenue, By Geography, 2010 2012 ($Million) 
      Table 132 Novo Nordisk: Total Revenue And R&D Expenses, 2010 2012 ($Billion) 
      Table 133 Novo Nordisk: Total Revenue, By Segment, 2010 2012 ($Billion) 
      Table 134 Novo Nordisk: Total Revenue, By Geography, 2010 2012 ($Billion) 
      Table 135 Sanofi: Total Revenue & R&D Expenditure, 2010 2012 ($Billion) 
      Table 136 Sanofi: Total Revenue, By Segment, 2010 - 2012 ($Billion)
      Table 137 Sanofi: Total Revenue, By Geography, 2010 - 2012 ($Billion)
      Table 138 Schott Ag: Total Revenue And R&D Expenditures, 2010 2012 ($Million) 
      Table 139 Schott Ag: Total Revenue, By Geography, 2010 2012 ($Million) 
      Table 140 Ypsomed: Total Revenue And R&D Expenses, 2009 - 2011 ($Million) 
      Table 141 Ypsomed: Total Revenue, By Segment, 2009 - 2011 ($Million)
      Table 142 Ypsomed: Total Revenue, By Geography, 2009 ($Million)
      Table 143 Ypsomed: Total Revenue, By Geography, 2010 - 2011 ($Million)
       
       
      List Of Figures  (26 Figures)
       
      Figure 1 Europe Injectable Drug Delivery Technologies Market, By Segment, 2012 & 2017 
      Figure 2 Injectable Drug Delivery Technologies Market, By Geography, 2012 
      Figure 3 Injectable Drug Delivery Technologies Market Segmentation
      Figure 4 Injectable Drug Delivery Technologies Market Segmentation
      Figure 5 Market Segmentation Of Injectable Drug Delivery Technologies, By Therapeutic Application
      Figure 6 Injectable Drug Delivery Technologies Market Dynamics
      Figure 7 Europeconventional Injection Devices Market, By Key Players, 2012 ($Million) 
      Figure 8 European Pen Injectors Market, By Key Players, 2012 ($Million) 
      Figure 9 Injectable Drug Delivery Devices Technologies Market Segmentation
      Figure 10 Factors Affecting Selection Of An Injectable Device
      Figure 11 European Self-Injection Devices Market, By Product, 2010 2017 ($Million) 
      Figure 12 Self-Injection Devices Market Segmentation
      Figure 13 Factors Affecting Selection Of Self-Injection Device
      Figure 14 Conventional Drug Delivery Formulation Technologies Market Segmentation
      Figure 15 Europe Novel Drug Delivey Formulation Market, 2012 & 2017 ($Million) 
      Figure 16 Novel Drug Delivery Formulation Technologies Segmentation
      Figure 17 Europe Injectable Drug Delivery Technologies Market, By Therapeutic Application, 2010 2017 ($Million) 
      Figure 18 Injectable Drug Delivery Technologies Market Segmentation, By Therapeutic Applications
      Figure 19 Auto-Immune Therapeutic Market Segmentation
      Figure 20 Hormonal Disorders Market Segmentation
      Figure 21 Key Growth Strategies, 2010 2013
      Figure 22 Key Growth Strategies, By Companies, 2010 2013
      Figure 23 Geographical Expansions, By Company, 2010 2013
      Figure 24 Agreements, Partnerships, Collaborations & Joint Ventures, By Company, 2010 2013
      Figure 25 New Product Launch, By Company, 2010 2013
      Figure 26 Mergers & Acquisitions, By Company, 2010 2013

      Injectable drug delivery technologies are a combination of two major segments - devices and formulations. The European injectable drug delivery formulations technologies market is the largest segment in the market. This is due to a surge of biologics and development of nanotechnologies. Based on product type, the injectable drug delivery devices market is further categorized as conventional injection devices, self-injection devices, and others (microneedles, nanoneedles and blunt needle injections), while the injectable drug delivery formulation technologies market is categorized as conventional drug delivery formulations and novel drug delivery formulations. The conventional injection devices segment accounted for the largest share of the European injectable drug delivery technologies market in 2012.

      The market is also segmented on the basis of its therapeutic applications as auto immune diseases, hormonal imbalances, oncology, orphan/rare diseases (Hemophilia, Ribose-5-phosphate isomerase deficiency (RPI deficiency), Cystic Fibrosis, and Wilsons disease) and others (pain management, allergies, hepatitis C, and aesthetic treatment). Hormonal disorders commanded the largest share of the European injectable drug delivery technologies market in 2012.

      The European injectable drug delivery market has witnessed challenging and dynamic market conditions (due to technological advancements and surge of biologics and biosimilars in pharmaceutical market) over the last five years. Newer products with better safety and efficacy contribute to the widespread adoption of injectable drug delivery technologiesby physicians and patients. However, factors such as needle-stick injuries and infections and development of alternate delivery methods (oral, nasal and topical) for injectable drugs are restraining the growth of the market.

      The key players in this market are Becton Dickinson & Co. (U.S.), Baxter International, Inc. (U.S.), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), Eli Lily & Co. (U.S.), Gerresheimer AG (Germany), Sanofi (France), West Pharmaceutical Services, Inc. (U.S.), Haselmeier GmbH (Germany), and Owen Mumford, Ltd. (U.K.).

      EUROPEAN INJECTABLE DRUG DELIVERY TECHNOLOGIES MARKET,BY GEOGRAPHY, 2012 ($BILLION)

      European Injectable Drug Delivery Technologies Market

      Source: Annual Reports, SEC Filings, Press Releases, Investor Presentations, Expert Interviews, MnM Analysis

      Custom Market Research Services

      We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

      Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

      Connect With Us

      Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
      Live Chat Support


      US : 1-888-600-6441
      UK : 44-800-368-9399

      Search reports